Source: British Cardiovascular Society
For full text link, click here
Year of Publication: 2009
Publication Type: News item
In a nutshell: The Dior drug-eluting balloon was launched at the Advanced Cardiovascular Intervention Meeting in London at the end of January. This ‘second generation’ drug-eluting balloon is coated with paclitaxel, which prevents restenosis of coronary stents. It can be used to treat both high-risk and low-risk percutaneous coronary intervention patients. It provides an alternative option to treat patients for whom stent implantation is not desirable.
Length of Publication: 1 page
Further dissemination: If you think anyone would benefit from receiving this posting or from subscribing to this blog, please e-mail them the link to this blog and suggest that they sign up to the blog’s e-mail newsletter to stay up-to-date with new content.
Acknowledgements: British Cardiovascular Society